跳至主要内容
临床试验/NCT06506487
NCT06506487已完成不适用

Exploratory Evaluation of Staff-Mediated Doll Therapy in Chinese Residential Dementia Care: A Mixed-Methods Cluster Randomized Pilot Trial

University of Malaya1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2024年7月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
142
试验地点
1
主要终点
Change in Daily Dose of Medication (DDM)

研究概览

简要总结

This study is a two-phase explanatory sequential mixed-methods study in Chinese residential dementia care. Phase I is a pragmatic 1:1 exploratory pilot cluster randomized trial in six nursing homes in Zhengzhou, China, comparing staff-mediated doll therapy plus routine nursing care with routine nursing care alone among 142 residents with dementia assessed at baseline, 6 weeks, and 12 weeks. Registered primary outcomes are class-specific daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants. Secondary and contextual outcomes include behavioral and psychological symptoms of dementia, activities of daily living, cognitive enhancer use, traditional Chinese medicine use, and doll engagement/adherence. Phase II uses semi-structured interviews with staff and family caregivers to explore acceptability, implementation, training needs, cultural fit, and ethical considerations.

详细描述

Doll therapy is a person-centered, attachment-informed non-pharmacological intervention in which a person living with dementia is offered a lifelike doll and may interact with it by holding, comforting, grooming, or talking to it. This exploratory pilot and feasibility mixed-methods cluster randomized trial evaluates a staff-mediated doll-therapy care package in Chinese nursing homes. Intervention homes receive staff training, a structured introduction to a personal doll, relational engagement during routine care, and ongoing monitoring of resident assent, dissent, distress, and fit. Control homes provide routine nursing care alone. Quantitative assessments are conducted at baseline, 6 weeks, and 12 weeks. Medication-related outcomes are interpreted as indirect health-service and medication-burden signals rather than as direct evidence of prescribing causation. Behavioral, functional, contextual medication, traditional Chinese medicine, and engagement measures are interpreted alongside qualitative interviews with staff and family caregivers to understand implementation, acceptability, cultural fit, and ethical safeguards. Because only six clusters are randomized, the study is intended to generate feasibility information, preliminary effect estimates, and implementation signals rather than definitive clinical-effect evidence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

盲法说明

The intervention was visible in routine care, so residents, direct caregivers, and intervention deliverers were not blinded. Medication outcomes were extracted from medication records by assessors masked to allocation where feasible; caregiver-reported NPI-12 and Barthel ratings could not be fully blinded.

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 65 years or older.
  • Nursing home resident with a documented clinical diagnosis of dementia recorded in the medical or nursing-home record by a qualified physician using DSM-5, ICD-10, ICD-11, or current Chinese clinical guidelines for dementia and cognitive impairment; where the underlying diagnostic criteria were not specified in the record, the site clinician reconfirmed the diagnosis against DSM-5 criteria before enrollment.
  • Adequate visual capacity to recognize a doll at screening.
  • Sufficient upper-limb function to hold or caress the doll safely.
  • Availability of a legally authorized representative able to provide written informed consent.
  • Resident assent whenever appropriate.

排除标准

  • Acute medical instability.
  • Severe sensory or physical limitations preventing safe participation.
  • Severe communication impairment precluding meaningful participation.
  • Major psychiatric disorders unrelated to dementia.
  • Resident dissent or refusal when assent was appropriate, or safety concerns that made doll interaction unsuitable.

研究组 & 干预措施

Staff-Mediated Doll Therapy plus Routine Nursing Care

Experimental

Residents in intervention homes received routine nursing care plus a staff-mediated doll-therapy care package. The package included staff training, a structured doll-therapy introduction with eight planned sessions over approximately 15 days, continued access to a personal doll during routine care, structured interaction and relational engagement, and ongoing monitoring of resident assent, dissent, distress, and fit.

干预措施: Doll Therapy (Behavioral)

Routine Nursing Care

No Intervention

Residents in control homes received routine nursing care alone. Control homes did not receive study-provided dolls or structured doll-therapy training during the study period.

结局指标

主要结局

Change in Daily Dose of Medication (DDM)

时间窗: 12 weeks

This primary outcome measure will assess the effectiveness of doll therapy in altering the daily dose of medications (DDM) required by participants. The daily dose of medications includes antipsychotics, antidepressants, anxiolytics, and cognitive enhancers, converted to standardized doses (e.g., chlorpromazine equivalents for antipsychotics, diazepam equivalents for anxiolytics, donepezil equivalents for cognitive enhancers, and defined daily dose (DDD) for antidepressants). The change in medication dosage will be measured and compared between the intervention group (doll therapy plus routine care) and the control group (routine care alone).

Change in Class-Specific Daily Medication Dose

时间窗: 12 weeks

This primary outcome assesses class-specific mean daily medication-dose trajectories for antipsychotics, anxiolytics, and antidepressants over 12 weeks. Antipsychotics are expressed as chlorpromazine-equivalent daily dose, anxiolytics as diazepam-equivalent daily dose, and antidepressants using the WHO defined daily dose framework. Changes are compared between doll therapy plus routine nursing care and routine care alone.

次要结局

  • Change in Behavioral and Psychological Symptoms of Dementia (BPSD)(12 weeks)
  • Change in Activities of Daily Living (ADL)(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhenti Cui

PhD Candidate

University of Malaya

研究点 (1)

Loading locations...

相似试验